PLoS ONE (Jan 2021)

Effects of the duration of bridge to lung transplantation with extracorporeal membrane oxygenation.

  • Dong Kyu Oh,
  • Sang-Bum Hong,
  • Tae Sun Shim,
  • Dong Kwan Kim,
  • Sehoon Choi,
  • Geun Dong Lee,
  • Won Kim,
  • Seung-Il Park

DOI
https://doi.org/10.1371/journal.pone.0253520
Journal volume & issue
Vol. 16, no. 7
p. e0253520

Abstract

Read online

BackgroundAlthough bridge to lung transplantation (BTT) with extracorporeal membrane oxygenation (ECMO) is increasingly performed, the impact of BTT and its duration on post-transplant outcomes are unclear.MethodsWe retrospectively reviewed medical records of adult patients who underwent lung or heart-lung transplantation in our institution between January 2008 and December 2018. Data were compared in patients who did (n = 41; BTT) and did not (n = 36; non-BTT) require pre-transplant ECMO support. Data were also compared in patients who underwent short-term (ResultsAmong 77 patients included, 51 (66.2%) were male and median age was 53 years. The median bridging time in the BTT group was 13 days (interquartile range [IQR], 7-19 days). Although simplified acute physiologic score II was significantly higher in the BTT group (median, 35; IQR, 31-49 in BTT group vs. median, 12; IQR, 7-19 in non-BTT group; pConclusionsDespite the severe illness, the BTT group showed favorable post-transplantation outcomes, particularly those bridged for less than 14 days.